Neuromuscular blocking agents in the intensive care unit
Neuromuscular blocking agents (NMBA) are a controversial therapeutic option in the approach to the critically ill patient. They are not innocuous, and the available evidence does not support their routine use in the intensive care unit. If necessary, monitoring protocols should be established to avo...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-09-01
|
Series: | Journal of International Medical Research |
Online Access: | https://doi.org/10.1177/03000605221128148 |